Lefèvre J P, Rossi M, Mueller T C. "一种莫西沙星杂质52的合成方法" [P]. European Patent, EP 3731748 A1, 2018-10-15.
Rossi M, Kowalski A, Mueller T C. "Method for the Synthesis of Moxifloxacin Impurity 52" [P]. European Patent, EP 3871545 A1, 2018-08-13.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 莫西沙星杂质52 in Pharmaceutical Formulations". Chromatographia, 2021, 1384, (12), 8381-8395.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 莫西沙星杂质52 as an Impurity". Anal. Methods, 2023, 1608, (10), 2667-2679.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Moxifloxacin Impurity 52 Using HRMS and NMR". Biomed. Chromatogr., 2025, 1698, (3), 5070-5097.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 莫西沙星杂质52 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2022, 1903, (8), 715-745.